Pure Biologics Spólka Akcyjna
PUR.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | PLN 36 | PLN 21 | PLN 58 | PLN 95 |
| - Cash | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| + Debt | PLN 15 | PLN 15 | PLN 14 | PLN 14 |
| Enterprise Value | PLN 50 | PLN 35 | PLN 72 | PLN 108 |
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | – | – | – | – |
| Gross Profit | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | – | – | – | – |
| EBITDA | -PLN 1 | -PLN 2 | -PLN 1 | -PLN 7 |
| % Margin | – | – | – | – |
| Net Income | -PLN 1 | -PLN 5 | -PLN 1 | -PLN 11 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.21 | -0.74 | -0.34 | -1.94 |
| % Growth | 71.6% | -117.6% | 82.5% | – |
| Operating Cash Flow | -PLN 0 | -PLN 0 | -PLN 1 | -PLN 4 |
| Capital Expenditures | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Free Cash Flow | -PLN 0 | -PLN 0 | -PLN 1 | -PLN 4 |